Keyphrases
Chronic Kidney Disease
100%
Estimated Glomerular Filtration Rate
73%
Confidence Interval
71%
Benign Prostatic Hyperplasia
59%
Placebo
50%
Older Men
40%
Cystatin C (Cys C)
40%
Hazard Ratio
39%
Renal Function
39%
Acute Kidney Injury
38%
Albuminuria
36%
Hemodialysis
36%
Systolic Blood Pressure Intervention Trial (SPRINT)
35%
Cardiovascular Mortality
34%
Egfr
33%
End-stage Renal Disease
32%
Randomized Controlled Trial
31%
Clinical Outcomes
31%
Electronic Health Records
31%
Diuretics
30%
Creatinine
29%
Hospitalization
28%
Cardiovascular Events
27%
Older Women
26%
United States
26%
Pragmatic Clinical Trial
25%
Dialysis
24%
Hemodialysis Patients
24%
All-cause Mortality
24%
Angiotensin-converting Enzyme Inhibitor (ACEi)
24%
Cardiovascular Outcomes
23%
Albumin-to-creatinine Ratio
23%
Hypertension Management
22%
Diabetes
22%
Clinical Practice Guidelines
22%
Dialysis Initiation
22%
Patient Outcomes
21%
Kidney Disease Outcomes Quality Initiative (KDOQI)
21%
Diabetic Kidney Disease
21%
Glomerular Filtration Rate
21%
Dialysis Patients
20%
Relative Risk
20%
Serum Creatinine
20%
Hypertension
20%
Cardiovascular Risk
19%
Medicare
19%
Cardiovascular Disease
19%
Hydrochlorothiazide
19%
Chlorthalidone
19%
Risk Factors
19%
Medicine and Dentistry
Chronic Kidney Disease
99%
Glomerular Filtration Rate
69%
Hemodialysis
67%
Kidney Function
62%
Prostate Hypertrophy
59%
End Stage Renal Disease
58%
Systematic Review
56%
Placebo
47%
Creatinine
45%
Clinical Trial
35%
Cardiovascular System
34%
Medicare
32%
Acute Kidney Injury
32%
Urinary System
29%
Diuretic Agent
28%
Nephropathy
25%
Intervention Trial
24%
Albuminuria
24%
Randomized Controlled Trial
22%
Drug Therapy
22%
Electronic Health Record
21%
Obstructive Sleep Apnea
21%
Primary Health Care
21%
Renal Replacement Therapy
21%
Outpatient
21%
Hazard Ratio
19%
Veterans Affairs
19%
Apoplexy
18%
Patient Characteristics
18%
Meta-Analysis
16%
Fragility Fracture
16%
Cohort Analysis
16%
Transplantation
16%
Cernitin
16%
Blood Transfusion
16%
Sodium Glucose Cotransporter 2 Inhibitor
16%
Cystatin C
15%
Blood Pressure
15%
Cardiovascular Disease
15%
Systolic Blood Pressure
15%
Serenoa
15%
Isotopes of Calcium
15%
Adverse Event
14%
Congestive Heart Failure
14%
Randomized Clinical Trial
13%
Hydrochlorothiazide
13%
Chlortalidone
13%
Proteinuria
13%
Diabetes
13%
Observational Study
12%